CCL2 and acute respiratory distress syndrome: Represses macrophage inflammatory protein 1a (MIP-1a), macrophage inflammatory protein 3a (MIP-3a), and Monocyte chemoattractant protein-1 (MCP-1) levels. Improves d-galactosamine (D-GalN)-induces ALI.